Home > Drug List > Pemigatinib > Indications of Pemigatinib

Indications of Pemigatinib

1.Cholangiocarcinoma

pemigatinib is indicated for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement as detected by an FDA-approved test.

2.Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement

pemigatinib is indicated for the treatment of adults with relapsed or refractory myeloid/lymphoid neoplasms (MLNs) with fibroblast growth factor receptor 1 (FGFR1) rearrangement.

from FDA，2022.08